Purchases and Sales Made in Q4 2023 in Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD) during Q4 2023. The information is specifically focused on institutions that hold shares of RELMADA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 22, 2024
Q4 2023
|
Parsons Capital Management Inc
|
SELL
|
- |
-24.2K- 2.49% |
$59.4K - $102K
|
950K
$389K
|
|
|
Feb 09, 2024
Q4 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-26K- 29.82% |
$63.7K - $110K
|
61.2K
$25.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-26.3K- 11.09% |
$64.4K - $111K
|
211K
$86.4K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
- |
-26.4K- 26.53% |
$64.7K - $111K
|
73.1K
$30K
|
|
|
Feb 14, 2024
Q4 2023
|
Rbf Capital, LLC
San Francisco, CA |
SELL
|
- |
-28.6K- 14.74% |
$70.1K - $121K
|
165K
$67.8K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-33.2K- 26.94% |
$81.4K - $140K
|
90.1K
$36.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Advisor Shares Investments LLC
Bethesda, MD |
SELL
|
- |
-38.2K- 33.87% |
$93.7K - $161K
|
74.7K
$30.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-56.4K- 13.06% |
$138K - $238K
|
376K
$154K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-145K- 42.18% |
$355K - $612K
|
199K
$81.5K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-296K- 94.03% |
$726K - $1.25M
|
18.8K
$7.71K
|
|
|
Feb 14, 2024
Q4 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-793K- 27.95% |
$1.94M - $3.35M
|
2.04M
$838K
|